Atlas Trials

Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia

Clinical trial NCT03323437 · COMPLETED

Trial details

NCT number
NCT03323437
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia Spectrum and Other Psychotic Disorders
Start date
2017-09-15
Primary completion
2023-05-31
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.